Skip to main content

Table 3 Medication of the patients at baseline and one year follow up

From: Symptomatic relief precedes improvement of myocardial blood flow in patients under spinal cord stimulation

 

Baseline (n = 31)

1 Year (n = 27)

Beta-blocker

31 (100%)

27 (100%)

ACE-Inhibior/AT 1 -Antagonist

29 (94%)

26 (96%)

Ca ++ -Antagonist

26 (84%)

24 (89%)

CSE-inhibitor

31 (100%)

27 (100%)

Long-acting nitrate

31 (100%)

25 (93%)

Morphine derivate

12 (39%)

1 (4%)

  1. Medication of the patients at baseline (n = 31) and one year follow up (n = 27). Before one year follow up SCS device was explanted in 3 patients (2 during test phase, one after 8 months). One patient died before last visit.